186 related articles for article (PubMed ID: 9076751)
1. Anticonvulsant activity of novel derivatives of 2- and 3-piperidinecarboxylic acid in mice and rats.
Hinko CN; Crider AM; Kliem MA; Steinmiller CL; Seo TH; Ho B; Venkatarangan P; el-Assadi AA; Chang H; Burns CM; Tietz EI; Andersen PH; Klitgaard H
Neuropharmacology; 1996; 35(12):1721-35. PubMed ID: 9076751
[TBL] [Abstract][Full Text] [Related]
2. Anticonvulsant profiles of the potent and orally active GABA uptake inhibitors SK&F 89976-A and SK&F 100330-A and four prototype antiepileptic drugs in mice and rats.
Swinyard EA; White HS; Wolf HH; Bondinell WE
Epilepsia; 1991; 32(4):569-77. PubMed ID: 1831122
[TBL] [Abstract][Full Text] [Related]
3. Anticonvulsant activity of the low-affinity uncompetitive N-methyl-D- aspartate antagonist (+-)-5-aminocarbonyl-10,11-dihydro-5H- dibenzo[a,d]cyclohepten-5,10-imine (ADCI): comparison with the structural analogs dizocilpine (MK-801) and carbamazepine.
Rogawski MA; Yamaguchi S; Jones SM; Rice KC; Thurkauf A; Monn JA
J Pharmacol Exp Ther; 1991 Oct; 259(1):30-7. PubMed ID: 1920122
[TBL] [Abstract][Full Text] [Related]
4. Classification of compounds for prevention of NMDLA-induced seizures/mortality, or maximal electroshock and pentylenetetrazol seizures in mice and antagonism of MK801 binding in vitro.
Palmer GC; Harris EW; Ray R; Stagnitto ML; Schmiesing RJ
Arch Int Pharmacodyn Ther; 1992; 317():16-34. PubMed ID: 1456842
[TBL] [Abstract][Full Text] [Related]
5. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy.
Klitgaard H; Matagne A; Gobert J; Wülfert E
Eur J Pharmacol; 1998 Jul; 353(2-3):191-206. PubMed ID: 9726649
[TBL] [Abstract][Full Text] [Related]
6. Anticonvulsant 1-phenylcycloalkylamines: two analogues with low motor toxicity when orally administered.
Blake PA; Yamaguchi S; Thurkauf A; Rogawski MA
Epilepsia; 1992; 33(1):188-94. PubMed ID: 1531130
[TBL] [Abstract][Full Text] [Related]
7. [S]-AR-R 15896AR-A novel anticonvulsant: acute safety, pharmacokinetic and pharmacodynamic properties.
Palmer GC; Murray RJ; Cramer CL; Stagnitto ML; Knowles MK; Freedman LR; Eismann MS; Mahmood N; Balestra M; Borrelli AR; Hudzik TJ; McCarthy DJ
J Pharmacol Exp Ther; 1999 Jan; 288(1):121-32. PubMed ID: 9862762
[TBL] [Abstract][Full Text] [Related]
8. Corneal kindling in mice: behavioral and pharmacological differences to conventional kindling.
Potschka H; Löscher W
Epilepsy Res; 1999 Nov; 37(2):109-20. PubMed ID: 10510977
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of CPP, a selective NMDA antagonist, in various rodent models of epilepsy. Comparison with other NMDA antagonists, and with diazepam and phenobarbital.
Löscher W; Nolting B; Hönack D
Eur J Pharmacol; 1988 Jul; 152(1-2):9-17. PubMed ID: 3061831
[TBL] [Abstract][Full Text] [Related]
10. Glycine derivatives of imidazolones as potential ligands of glycine binding site of NMDA receptors. Part 1.
Kieć-Kononowicz K; Karolak-Wojciechowska J; Handzlik J
Acta Pol Pharm; 1998; 55(5):381-8. PubMed ID: 9921116
[TBL] [Abstract][Full Text] [Related]
11. Interaction of the neurosteroid alphaxalone with conventional antiepileptic drugs in different types of experimental seizures.
Borowicz KK; Zadrozniak M; Swiader M; Kowalska A; Kleinrok Z; Czuczwar SJ
Eur J Pharmacol; 2002 Aug; 449(1-2):85-90. PubMed ID: 12163110
[TBL] [Abstract][Full Text] [Related]
12. Effects of amygdaloid kindling on NMDA receptor function and regulation.
Jones SM; Johnson KM
Exp Neurol; 1989 Oct; 106(1):52-60. PubMed ID: 2571516
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological profile of NPC 17742 [2R,4R,5S-(2-amino-4,5-(1, 2-cyclohexyl)-7-phosphonoheptanoic acid)], a potent, selective and competitive N-methyl-D-aspartate receptor antagonist.
Ferkany JW; Hamilton GS; Patch RJ; Huang Z; Borosky SA; Bednar DL; Jones BE; Zubrowski R; Willetts J; Karbon EW
J Pharmacol Exp Ther; 1993 Jan; 264(1):256-64. PubMed ID: 8423528
[TBL] [Abstract][Full Text] [Related]
14. Effects of the competitive NMDA receptor antagonist, CGP 37849, on anticonvulsant activity and adverse effects of valproate in amygdala-kindled rats.
Löscher W; Hönack D
Eur J Pharmacol; 1993 Apr; 234(2-3):237-45. PubMed ID: 8097722
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and anticonvulsant and neurotoxic properties of substituted N-phenyl derivatives of the phthalimide pharmacophore.
Vamecq J; Bac P; Herrenknecht C; Maurois P; Delcourt P; Stables JP
J Med Chem; 2000 Apr; 43(7):1311-9. PubMed ID: 10753468
[TBL] [Abstract][Full Text] [Related]
16. Preclinical evaluation of CHF3381 as a novel antiepileptic agent.
Villetti G; Bregola G; Bassani F; Bergamaschi M; Rondelli I; Pietra C; Simonato M
Neuropharmacology; 2001 Jun; 40(7):866-78. PubMed ID: 11378157
[TBL] [Abstract][Full Text] [Related]
17. Are neuronal nicotinic receptors a target for antiepileptic drug development? Studies in different seizure models in mice and rats.
Löscher W; Potschka H; Wlaź P; Danysz W; Parsons CG
Eur J Pharmacol; 2003 Apr; 466(1-2):99-111. PubMed ID: 12679146
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the anticonvulsant properties of ganaxolone (CCD 1042; 3alpha-hydroxy-3beta-methyl-5alpha-pregnan-20-one), a selective, high-affinity, steroid modulator of the gamma-aminobutyric acid(A) receptor.
Carter RB; Wood PL; Wieland S; Hawkinson JE; Belelli D; Lambert JJ; White HS; Wolf HH; Mirsadeghi S; Tahir SH; Bolger MB; Lan NC; Gee KW
J Pharmacol Exp Ther; 1997 Mar; 280(3):1284-95. PubMed ID: 9067315
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the anticonvulsant properties of F-721.
Swinyard EA; Wolf HH; White HS; Skeen GA; Stark LG; Albertson T; Pong SF; Drust EG
Epilepsy Res; 1993 May; 15(1):35-45. PubMed ID: 8391982
[TBL] [Abstract][Full Text] [Related]
20. Anticonvulsant activity of antagonists for the NMDA-associated glycine binding site.
Nichols AC; Yielding KL
Mol Chem Neuropathol; 1993 Aug; 19(3):269-82. PubMed ID: 8397587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
